Evidence map›Paper›PMID 35447340›Full record

ArticleBiochimica et biophysica acta. Molecular basis of disease2022

FGF1

Qian Lin, Oscar Chen, John P Wise, HongXue Shi, Kupper A Wintergerst, Lu Cai, Yi Tan

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biochimica et biophysica acta. Molecular basis of disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Human FGF1Cells · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Qian LinPediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA. Electronic address: qian.lin@louisville.edu.
Oscar ChenPediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA.
John P WisePediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA.
HongXue ShiPediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Kupper A WintergerstPediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Division of Endocrinology, Department of Pediatrics, University of Louisville, Louisville, KY, USA; Wendy L. Novak Diabetes Care Center, Louisville, KY, USA.
Lu CaiPediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Wendy L. Novak Diabetes Care Center, Louisville, KY, USA.
Yi TanPediatic Research Institute, Departments of Pediatrics, Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY, USA; Wendy L. Novak Diabetes Care Center, Louisville, KY, USA. Electronic address: yi.tan@louisville.edu.
University of Louisville · US

Funding

Fibroblast Growth Factor 1 Prevents Hyperlipidemia and atherosclerosisR01HL160927 · NHLBI · UNIVERSITY OF LOUISVILLE · PI Yi Tan · 2022 to 2026
$2.7M
A novel mechanism of stromal cell-derived factor 1 protection against diabetic cardiomyopathyR01HL125877 · NHLBI · UNIVERSITY OF LOUISVILLE · PI TAN, YI · 2017 to 2021
$1.9M
NHLBI NIH HHS R01 HL125877NHLBI NIH HHS R01 HL160927
6 · The paper itself

Abstract

Elderly adults are at higher risk for developing diabetic complications including diabetic nephropathy (DN), contributing to excess morbidity and mortality in elderly individuals. A non-mitogenic variant of fibroblast growth factor 1 (FGF1

Indexed as

Diabetes Mellitus, Type 2Diabetic NephropathiesFibroblast Growth Factor 1AnimalsApoptosisDisease Models, AnimalFibrosisHumansInflammationMicePPAR alphaFibroblast Growth Factor 1PPAR alphaApoptosisDiabetic nephropathyFGF1(ΔHBS)FibrosisInflammationType 2 diabetes

Identifiers

PMID35447340
PMCPMC9617478
OpenAlexW4224123169

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.